Mode
Text Size
Log in / Sign up
N/A N=110 Randomized Double-blind Treatment

Cognitive Rehabilitation for PD

Parkinson's Disease

Enrolled (actual)
110
Serious AEs
0.9%
Results posted
Jun 2020
Primary outcome: Primary: Wechsler Adult Intelligence Scale-IV (WAIS-IV) Matrix Reasoning Test Total Scaled Score — 0.22; 0.42 score on a scale — p=0.6662

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
CogSMART-PD (Behavioral); Supportive Care (Behavioral)
Age
Adult, Older Adult · 40+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Apr 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Wechsler Adult Intelligence Scale-IV (WAIS-IV) Matrix Reasoning Test Total Scaled Score
0.22; 0.42 0.6662
SECONDARY
Delis-Kaplan Executive Functioning System (D-KEFS): 20 Questions Test Total Questions Asked Scaled Score
-0.09; 1.06 0.0496 sig
SECONDARY
Informant Questionnaire on Cognitive Decline in the Elderly-Self Report (IQCODE-SR) Total Score
-5.51; -8.86 0.047 sig
SECONDARY
Cognitive Problems and Strategies Assessment (CPSA) Memory Strategies Use Score
-0.24; 10.17 0.001 sig
SECONDARY
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) Total Score
-4.49; -10.46 0.020 sig
SECONDARY
Memory for Intention Test (MIST) Total Score
4; 2.82 0.444
SECONDARY
World Health Organization Quality of Life (WHOQOL)-BREF Psychological Domain Transformed Score
4.02; 0.04 0.073
SECONDARY
Parkinson's Disease Questionnaire-39 (PDQ-39) Total Score
-2.31; -2.69 0.82
SECONDARY
Neuropsychiatric Inventory-Questionnaire (NPI-Q) Total Month Score
1.82; -2.30 0.0263 sig

Summary

To investigate the effectiveness of a novel compensatory cognitive rehabilitation program for individuals with Parkinson's disease (PD) and mild cognitive impairment (MCI).

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of Parkinson's disease
  • Mild Cognitive Impairment
  • Over 40 years of age
  • Fluent English speaker

Exclusion Criteria

Other neurological conditions (e.g., stroke) besides Parkinson's disease

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03335150). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search